Please assess the completion status of the following clinical trial:

Trial Title: Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic stroke within 3 months of study entry~* Admitted to a UPMC hospital for acute inpatient treatment or rehabilitation of stroke~* Speaks English~* Females willing to use an effective form of birth control throughout the study~Exclusion Criteria:~* Meets DSM-IV-TR criteria for a major depressive episode~* History of any bipolar disorder~* Psychotic or history of a psychotic disorder~* Meets DMS-IV TR criteria for alcohol or substance abuse or dependence criteria within 3 months of study entry~* Current treatment with antidepressant medication for any reason (e.g., anxiety disorder, neuropathic pain)~* Primary hemorrhagic stroke~* Language impairment severe enough to prevent valid neuropsychiatric assessment~* History of another CNS disease other than prior stroke or psychiatric illness (e.g., head trauma, multiple sclerosis, HIV with CNS involvement)~* Pulse \<50 or \>100 beats per minute~* Significant hyponatremia (Na \<130meq)~* Current hypothyroid state~* Medically unstable including symptoms of delirium (determined by review of the subject's medical status with the treating (clinical) physician; standard blood chemistry lab work will be obtained if not checked within the preceding 30 days)~* History of sensitivity to sertraline~* Pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Sertraline
- 2 (Type: PLACEBO_COMPARATOR): matching placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).